Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMBINATION THERAPY
Document Type and Number:
WIPO Patent Application WO/2019/140030
Kind Code:
A1
Abstract:
The disclosure describes a combination therapy for treating diabetes or chronic kidney disease by administering to a patient in need of such treatment an effective amount of a urocortin-2 compound (or a pharmaceutically acceptable salt thereof) with a GIP/GLP-1 co-agonist analog (or a pharmaceutically acceptable salt thereof), and to methods of using the same to treat diabetes and chronic kidney disease.

Inventors:
ALSINA-FERNANDEZ JORGE (US)
COSKUN TAMER (US)
Application Number:
PCT/US2019/012963
Publication Date:
July 18, 2019
Filing Date:
January 10, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LILLY CO ELI (US)
International Classes:
A61K38/26; A61K38/22; A61P3/10
Domestic Patent References:
WO2018013803A12018-01-18
WO2008047241A22008-04-24
WO2016111971A12016-07-14
WO2013164483A12013-11-07
WO2014192284A12014-12-04
WO2011119657A12011-09-29
Foreign References:
US9474780B22016-10-25
Other References:
MEI HUA GAO ET AL: "One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistance", JCI INSIGHT, vol. 1, no. 15, 22 September 2016 (2016-09-22), XP055410687, DOI: 10.1172/jci.insight.88322
MACKAY ET AL., EURO. J. PHARMACOL., vol. 469, 2003, pages 111 - 115
GREEN; WUTS: "Protecting Groups in Organic Synthesis", 1991, JOHN WILEY & SONS
REMINGTON: "The Science and Practice of Pharmacy", 2006, LIPPINCOTT, WILLIAMS & WILKINS
STAHL ET AL.: "Handbook of Pharmaceutical Salts: Properties, Selection and Use", 2011, WILEY-VCH
BERGE ET AL., J. PHARMA SCI., vol. 66, 1977, pages 1 - 19
SURWIT ET AL., DIABETES, vol. 37, 1988, pages 1163 - 1167
Attorney, Agent or Firm:
CHOLEWA, Brian C. et al. (US)
Download PDF: